Antibody-drug conjugates (ADCs) have transformed metastatic breast cancer (mBC) care, offering new opportunities to personalize treatment across disease subtypes and improve patient outcomes.Join a leading mBC expert and a community oncologist in this engaging webcast highlighting practical strategies for ADC integration sourced from recent sessions at community oncology clinics. Through case-based discussions and unique patient perspectives, faculty share actionable approaches for evidence-based treatment selection, sequencing, toxicity management, and multidisciplinary care coordination. This dynamic session is designed to enhance your understanding and optimize clinical workflows for safe, effective ADC use.Two downloadable resources are available to support implementation in practice:The Easy as ADC – Infusion Center Resource, a provider-focused guide equipping infusion teams with clinical strategies for ADC administration, monitoring, and adverse-event managementThe ADC Treatment Tracker – Patient Education Tool, a patient-centered tool that can be shared with patients to help them understand their therapy, monitor symptoms, and support treatment continuity.Don’t miss this opportunity to gain valuable insights and practical tools to elevate care for your patients with mBC.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Case-based learning
- includes On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
Available fromOct 30, 2026
-
Last day to claim creditOct 30, 2027 1 year left
-
Physicians’ Education Resource The ADC Revolution in Metastatic Breast Cancer: Redefining Treatment Selection and Sequencing
-
Efficient CME, CME Outfitters, LLC Time-Out! Troubleshooting Evolving Situations Related to the Integration of Novel Antibody Drug Conjugates into the Management of HER2-Positive Early Breast Cancer
-
Learner’s Digest International (TM) Antibody Drug Conjugates in Advanced HR+/HER2 Breast Cancer and Triple-Negative Breast Cancer
-
PRIME Education, Inc. (PRIME®) Integrating Trop-2 Directed ADCs Into HR+/HER2- Breast Cancer Care
-
PRIME Education, Inc. (PRIME®) Risk Stratification and Tailoring Treatment in HER2+ Early Breast Cancer
-
PRIME Education, Inc. (PRIME®) Mastering ADC Implementation: Sequencing, Toxicity Management, and Multidisciplinary Decision-Making in PROC
